TriSalus Life Sciences reported earnings of -$ 0.15 per TLSI share on Nov 10, 2026, beating analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.13 |
| Earnings Per Share (Surprise) | -$ 0.15 (-$ 0.02) |
| Last Year's EPS | -$ 0.44 |
| EPS YoY Change |
Out of the last 24 earnings reporting periods, TriSalus Life Sciences beat analysts’ expectations 3 times and fell short of expectations 8 time(s). TriSalus Life Sciences reported earnings per share of -$ 0.15 in the last report falling to reach an estimated EPS of -$ 0.13 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.13 | -$ 0.15 | -$ 0.96 | |
| Aug 6, 2026 | -$ 0.16 | -$ 0.16 | -$ 0.27 | |
| May 12, 2026 | -$ 0.16 | -$ 0.33 | -$ 0.33 | |
| Mar 5, 2026 | -$ 0.13 | -$ 0.21 | -$ 0.35 | |
| Nov 13, 2025 | -$ 0.17 | -$ 0.96 | -$ 0.12 | |
| Aug 12, 2025 | -$ 0.22 | -$ 0.27 | -$ 0.21 | |
| May 15, 2025 | -$ 0.20 | -$ 0.33 | -$ 0.60 | |
| Mar 27, 2025 | -$ 0.35 | -$ 0.35 | -$ 1.34 | |
| Nov 14, 2024 | -$ 0.36 | -$ 0.12 | -$ 0.13 | |
| Aug 14, 2024 | -$ 0.49 | -$ 0.21 | -$ 0.89 | |
| May 15, 2024 | -$ 0.65 | -$ 0.60 | -$ 0.53 | |
| Mar 12, 2024 | -$ 0.69 | -$ 1.34 | -$ 0.31 | |
| Nov 14, 2023 | - | -$ 0.13 | -$ 0.76 | |
| Aug 2, 2023 | - | -$ 0.89 | -$ 0.26 | |
| Jun 30, 2023 | - | -$ 0.53 | $ 0.07636 | |
| Mar 31, 2023 | - | -$ 0.31 | -$ 0.25 | |
| Dec 31, 2022 | - | -$ 0.76 | $ 0.09266 | |
| Nov 10, 2022 | - | -$ 0.26 | $ 0.0597 | |
| Aug 10, 2022 | - | $ 0.07636 | $ 0.01212 | |
| May 11, 2022 | - | -$ 0.25 | -$ 0.01 |
TriSalus Life Sciences’s stock was trading at $ 3.22 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, TLSI’s price decreased to $ 2.30 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.15 | $ 3.22 | $ 2.30 | |
| Aug 6, 2026 | -$ 0.16 | $ 4.62 | $ 5.61 | |
| May 12, 2026 | -$ 0.33 | $ 4.54 | $ 2.67 | |
| Mar 5, 2026 | -$ 0.21 | $ 5.00 | $ 4.47 | |
| Nov 13, 2025 | -$ 0.96 | $ 4.42 | $ 4.56 | |
| Aug 12, 2025 | -$ 0.27 | $ 3.57 | $ 3.95 | |
| May 15, 2025 | -$ 0.33 | $ 4.90 | $ 5.14 | |
| Mar 27, 2025 | -$ 0.35 | $ 5.58 | $ 5.62 | |
| Nov 14, 2024 | -$ 0.12 | $ 4.50 | $ 3.93 | |
| Aug 14, 2024 | -$ 0.21 | $ 5.75 | $ 5.89 | |
| May 15, 2024 | -$ 0.60 | $ 10.15 | $ 9.70 | |
| Mar 12, 2024 | -$ 1.34 | $ 9.71 | $ 9.31 | |
| Nov 14, 2023 | -$ 0.13 | $ 4.01 | $ 3.92 | |
| Aug 2, 2023 | -$ 0.89 | $ 10.27 | $ 9.50 | |
| Jun 30, 2023 | -$ 0.53 | $ 10.48 | $ 10.50 | |
| Mar 31, 2023 | -$ 0.31 | $ 10.20 | $ 10.29 | |
| Dec 31, 2022 | -$ 0.76 | $ 10.03 | $ 10.05 | |
| Nov 10, 2022 | -$ 0.26 | $ 10.02 | $ 10.02 | |
| Aug 10, 2022 | $ 0.07636 | $ 9.90 | $ 9.89 | |
| May 11, 2022 | -$ 0.25 | $ 9.82 | $ 9.81 |
TriSalus Life Sciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
TriSalus Life Sciences missed analysts’ expectations during the last earnings period by
